about
Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cellsThe immune profile associated with acute allergic asthma accelerates clearance of influenza virusCharacteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis.Systemic administration of IGF-I enhances healing in collagenous extracellular matrices: evaluation of loaded and unloaded ligamentsMaintenance of naïve CD8 T cells in nonagenarians by leptin, IGFBP3 and T3.Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axisIGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells.Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis.C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs.Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failureIGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment.Pathobiology and chemoprevention of bladder cancerHepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.IGFBP-3 may trigger osteoarthritis by inducing apoptosis of chondrocytes through Nur77 translocationMolecular pathways in bladder cancer: part 1.Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumorsSkeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients.GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells.Targeting caspase 8 to reduce the formation of metastases in neuroblastoma.Bi-compartmental communication contributes to the opposite proliferative behavior of Notch1-deficient hair follicle and epidermal keratinocytes.Signaling mechanisms involved in the response to genotoxic stress and regulating lifespan.Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancerRapamycin inhibits growth factor-induced cell cycle regulation in pancreatic beta cellsProstate cancer and acromegaly.IGF-I, insulin and prostate cancer.Clinical trials of resveratrol.PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer.Resveratrol in the management of human cancer: how strong is the clinical evidence?Molecular markers in bladder cancer: Novel research frontiers.Long-term hypoxia exposure enhanced IGFBP-3 protein synthesis and secretion resulting in cell apoptosis in H9c2 myocardial cells.Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote pro-survival capability via IGF-IR/PI3K/Akt signaling pathway activation.The antitumor effect of GDC-0941 alone and in combination with rapamycin in breast cancer cells.Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses.Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cellsProstatic disorders in acromegalic patients experience of a Brazilian center.Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.Apoptosis may determine the release of skeletal alkaline phosphatase activity from human osteoblast-line cells.
P2860
Q28139221-E8B6A715-C77B-4695-A099-B8830BAC2FEBQ30358384-DEA1EB44-71AA-4F8C-BF63-62B4D851D64EQ33183385-7DFAAC26-37C6-41FD-A636-1F777848C7C0Q33280034-79B1B64F-FB80-49D3-A28C-CD346F9F9CA7Q33745338-536C61DA-2710-42C8-96A6-C72229D48E34Q34263336-0B7726F8-71B4-4F23-A5C6-923B7789D173Q34316229-169F2D36-20BC-4176-B29B-52DA18187243Q34356588-1B85B694-6A04-4BFA-879D-E0CF796E5C65Q34695649-B8B8E7C0-2C7C-4654-9682-57315E89DB01Q34789354-A0FD8FDC-3309-450E-9F71-E373E5D2E94CQ34958147-022D344C-CB78-4AA9-AF67-B52D3BCD8A57Q35131260-5F13F585-6BCF-4ECB-9A4D-95C5725B3CB6Q35165700-3772A4F7-1A21-4236-A96E-599786E2F8A3Q35219328-54F17213-98E6-426A-8BDC-CEE04A75DAA0Q35746164-59FBBEE4-5B86-4EA5-9B1F-C79270D7B343Q35925681-15FE9249-CD39-458C-B0EE-7949F5B73222Q36037507-43C4A30E-83A7-4EFB-B02D-C07E3B2088CEQ36087611-7115CC97-FC99-4F2F-A764-53E2E82697F5Q36429626-7B47CF38-0441-41BF-820B-42EE46F47235Q36547331-E3FBC69A-F68D-4151-AF5A-1E8EE7C926D0Q36596680-0FBD85E6-0B1E-4342-A0BE-F6B36AB48FE4Q36973790-950EAEFD-B4C2-4969-AF8B-D8C4797367B7Q37006339-58A19FCF-1CBC-4831-BCEE-DD317E48F3A0Q37056885-6EE5A364-D248-489F-A10E-8D5DA116FB84Q37259485-C5CED53D-D7E2-4FF7-A6A9-F6274685CEA3Q37686151-BE7853D6-D10E-48C6-855F-950DAB7BF15DQ37686154-44CB687E-DDDF-448B-8B0C-E2D01E8E3714Q37831946-D551ADF2-2D94-4DEB-9E11-2407618D1B94Q37929638-EA0A8EEA-A5D5-4971-AC9D-36590025A6B3Q38121595-779673A6-FAD9-4AAF-9CA5-F5BD452D38A4Q38520403-F5E6793A-8759-4FB6-9D6B-A09947EB8306Q38837884-09815A7F-6640-4CC4-B1C0-F28BC86DB6E4Q39102933-20D673A4-78B6-401A-8780-04F938EAC027Q39272804-CB99E822-C806-4563-98FB-1922146B5FFEQ39455066-1293BC4E-F6F6-4F2B-B505-A9E7E0EC77ADQ39461923-6813DDA7-17BC-43BC-B469-D42C4B6086EDQ39488300-E344BBED-F824-45D2-95C5-FAB2AC0BD5E4Q40123781-C0B95D5B-6F07-42A6-ACEF-7880AE3B95D7Q40679032-4E3592D4-FD70-4840-B318-2B8C680BA779Q40728620-9C9FE4DB-7BF5-4576-A925-60C99DFC4A67
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The IGF axis and programmed cell death.
@ast
The IGF axis and programmed cell death.
@en
type
label
The IGF axis and programmed cell death.
@ast
The IGF axis and programmed cell death.
@en
prefLabel
The IGF axis and programmed cell death.
@ast
The IGF axis and programmed cell death.
@en
P2093
P1476
The IGF axis and programmed cell death.
@en
P2093
P304
P356
10.1046/J.1440-1711.1999.00822.X
P577
1999-06-01T00:00:00Z